(Q46778392)

25 December 2017

title

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study (English)

1 reference

25 December 2017

0 references

1 reference

Motasim Badri

1

0 references

Robin Wood

series ordinal

3

object named as

Robin Wood

1 reference

25 December 2017

Douglas Wilson

2

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

359

1 reference

25 December 2017

page(s)

2059-2064

1 reference

25 December 2017

issue

9323

1 reference

25 December 2017

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908904-3

7 January 2021

10.1016/S0140-6736(02)08904-3

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

12086758

1 reference

25 December 2017